0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Corticosteroid Injections for Joint Pain Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-13D9473
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global Corticosteroid Injections for Joint Pain Market Insights and Forecast to 2028

Global Corticosteroid Injections for Joint Pain Market Insights and Forecast to 2028

Code: QYRE-Auto-13D9473
Report
January 2022
110 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Corticosteroid Injections products used for Joint Pain.
Market Analysis and Insights: Global Corticosteroid Injections for Joint Pain Market

Due to the COVID-19 pandemic, the global Corticosteroid Injections for Joint Pain market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Knee & Ankle accounting for % of the Corticosteroid Injections for Joint Pain global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Corticosteroid Injections for Joint Pain market size is valued at US$ million in 2021, while the US and Europe Corticosteroid Injections for Joint Pain are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Corticosteroid Injections for Joint Pain landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Corticosteroid Injections for Joint Pain include Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet and SEIKAGAKU and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Corticosteroid Injections for Joint Pain Scope and Segment
Corticosteroid Injections for Joint Pain market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Corticosteroid Injections for Joint Pain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of the Spine
Others

Segment by Application

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

BY COMPANY

Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Corticosteroid Injections for Joint Pain Product Introduction
1.2 Market by Type
1.2.1 Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Knee & Ankle
1.2.3 Hip Joint
1.2.4 Shoulder & Elbow
1.2.5 Facet Joints of the Spine
1.2.6 Others
1.3 Market by Application
1.3.1 Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Corticosteroid Injections for Joint Pain Sales Estimates and Forecasts 2017-2028
2.2 Global Corticosteroid Injections for Joint Pain Revenue Estimates and Forecasts 2017-2028
2.3 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Corticosteroid Injections for Joint Pain Sales by Region
2.4.1 Global Corticosteroid Injections for Joint Pain Sales by Region (2017-2022)
2.4.2 Global Sales Corticosteroid Injections for Joint Pain by Region (2023-2028)
2.5 Global Corticosteroid Injections for Joint Pain Revenue by Region
2.5.1 Global Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022)
2.5.2 Global Corticosteroid Injections for Joint Pain Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Corticosteroid Injections for Joint Pain Sales by Manufacturers
3.1.1 Global Top Corticosteroid Injections for Joint Pain Manufacturers by Sales (2017-2022)
3.1.2 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Corticosteroid Injections for Joint Pain in 2021
3.2 Global Corticosteroid Injections for Joint Pain Revenue by Manufacturers
3.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Manufacturers (2017-2022)
3.2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Corticosteroid Injections for Joint Pain Revenue in 2021
3.3 Global Corticosteroid Injections for Joint Pain Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Corticosteroid Injections for Joint Pain Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Corticosteroid Injections for Joint Pain Sales by Type
4.1.1 Global Corticosteroid Injections for Joint Pain Historical Sales by Type (2017-2022)
4.1.2 Global Corticosteroid Injections for Joint Pain Forecasted Sales by Type (2023-2028)
4.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
4.2 Global Corticosteroid Injections for Joint Pain Revenue by Type
4.2.1 Global Corticosteroid Injections for Joint Pain Historical Revenue by Type (2017-2022)
4.2.2 Global Corticosteroid Injections for Joint Pain Forecasted Revenue by Type (2023-2028)
4.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
4.3 Global Corticosteroid Injections for Joint Pain Price by Type
4.3.1 Global Corticosteroid Injections for Joint Pain Price by Type (2017-2022)
4.3.2 Global Corticosteroid Injections for Joint Pain Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Corticosteroid Injections for Joint Pain Sales by Application
5.1.1 Global Corticosteroid Injections for Joint Pain Historical Sales by Application (2017-2022)
5.1.2 Global Corticosteroid Injections for Joint Pain Forecasted Sales by Application (2023-2028)
5.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
5.2 Global Corticosteroid Injections for Joint Pain Revenue by Application
5.2.1 Global Corticosteroid Injections for Joint Pain Historical Revenue by Application (2017-2022)
5.2.2 Global Corticosteroid Injections for Joint Pain Forecasted Revenue by Application (2023-2028)
5.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
5.3 Global Corticosteroid Injections for Joint Pain Price by Application
5.3.1 Global Corticosteroid Injections for Joint Pain Price by Application (2017-2022)
5.3.2 Global Corticosteroid Injections for Joint Pain Price Forecast by Application (2023-2028)
6 North America
6.1 North America Corticosteroid Injections for Joint Pain Market Size by Type
6.1.1 North America Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
6.1.2 North America Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
6.2 North America Corticosteroid Injections for Joint Pain Market Size by Application
6.2.1 North America Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
6.2.2 North America Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
6.3 North America Corticosteroid Injections for Joint Pain Market Size by Country
6.3.1 North America Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
6.3.2 North America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Corticosteroid Injections for Joint Pain Market Size by Type
7.1.1 Europe Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
7.1.2 Europe Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
7.2 Europe Corticosteroid Injections for Joint Pain Market Size by Application
7.2.1 Europe Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
7.2.2 Europe Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
7.3 Europe Corticosteroid Injections for Joint Pain Market Size by Country
7.3.1 Europe Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
7.3.2 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Type
8.1.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
8.1.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
8.2 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Application
8.2.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
8.2.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
8.3 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Region
8.3.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2017-2028)
8.3.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Corticosteroid Injections for Joint Pain Market Size by Type
9.1.1 Latin America Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
9.1.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
9.2 Latin America Corticosteroid Injections for Joint Pain Market Size by Application
9.2.1 Latin America Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
9.2.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
9.3 Latin America Corticosteroid Injections for Joint Pain Market Size by Country
9.3.1 Latin America Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
9.3.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Type
10.1.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
10.1.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
10.2 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Application
10.2.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
10.2.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
10.3 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Country
10.3.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
10.3.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Anika Therapeutics
11.4.1 Anika Therapeutics Corporation Information
11.4.2 Anika Therapeutics Overview
11.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Anika Therapeutics Recent Developments
11.5 Ferring
11.5.1 Ferring Corporation Information
11.5.2 Ferring Overview
11.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ferring Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ferring Recent Developments
11.6 Bioventus
11.6.1 Bioventus Corporation Information
11.6.2 Bioventus Overview
11.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bioventus Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bioventus Recent Developments
11.7 Flexion Therapeutics
11.7.1 Flexion Therapeutics Corporation Information
11.7.2 Flexion Therapeutics Overview
11.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Flexion Therapeutics Recent Developments
11.8 Zimmer Biomet
11.8.1 Zimmer Biomet Corporation Information
11.8.2 Zimmer Biomet Overview
11.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zimmer Biomet Recent Developments
11.9 SEIKAGAKU
11.9.1 SEIKAGAKU Corporation Information
11.9.2 SEIKAGAKU Overview
11.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SEIKAGAKU Recent Developments
11.10 Chugai Pharma
11.10.1 Chugai Pharma Corporation Information
11.10.2 Chugai Pharma Overview
11.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Chugai Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Corticosteroid Injections for Joint Pain Industry Chain Analysis
12.2 Corticosteroid Injections for Joint Pain Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Corticosteroid Injections for Joint Pain Production Mode & Process
12.4 Corticosteroid Injections for Joint Pain Sales and Marketing
12.4.1 Corticosteroid Injections for Joint Pain Sales Channels
12.4.2 Corticosteroid Injections for Joint Pain Distributors
12.5 Corticosteroid Injections for Joint Pain Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Corticosteroid Injections for Joint Pain Industry Trends
13.2 Corticosteroid Injections for Joint Pain Market Drivers
13.3 Corticosteroid Injections for Joint Pain Market Challenges
13.4 Corticosteroid Injections for Joint Pain Market Restraints
14 Key Findings in The Global Corticosteroid Injections for Joint Pain Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Knee & Ankle
    Table 3. Major Manufacturers of Hip Joint
    Table 4. Major Manufacturers of Shoulder & Elbow
    Table 5. Major Manufacturers of Facet Joints of the Spine
    Table 6. Major Manufacturers of Others
    Table 7. Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Corticosteroid Injections for Joint Pain Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)
    Table 10. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2022)
    Table 11. Global Corticosteroid Injections for Joint Pain Sales by Region (2023-2028) & (K Units)
    Table 12. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2023-2028)
    Table 13. Global Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2022)
    Table 15. Global Corticosteroid Injections for Joint Pain Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2023-2028)
    Table 17. Global Corticosteroid Injections for Joint Pain Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Corticosteroid Injections for Joint Pain Sales Share by Manufacturers (2017-2022)
    Table 19. Global Corticosteroid Injections for Joint Pain Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers (2017-2022)
    Table 21. Corticosteroid Injections for Joint Pain Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Corticosteroid Injections for Joint Pain Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Corticosteroid Injections for Joint Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroid Injections for Joint Pain as of 2021)
    Table 24. Corticosteroid Injections for Joint Pain Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Corticosteroid Injections for Joint Pain Product Offered
    Table 26. Date of Manufacturers Enter into Corticosteroid Injections for Joint Pain Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
    Table 29. Global Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
    Table 30. Global Corticosteroid Injections for Joint Pain Sales Share by Type (2017-2022)
    Table 31. Global Corticosteroid Injections for Joint Pain Sales Share by Type (2023-2028)
    Table 32. Global Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Corticosteroid Injections for Joint Pain Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Corticosteroid Injections for Joint Pain Revenue Share by Type (2017-2022)
    Table 35. Global Corticosteroid Injections for Joint Pain Revenue Share by Type (2023-2028)
    Table 36. Corticosteroid Injections for Joint Pain Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Corticosteroid Injections for Joint Pain Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
    Table 39. Global Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
    Table 40. Global Corticosteroid Injections for Joint Pain Sales Share by Application (2017-2022)
    Table 41. Global Corticosteroid Injections for Joint Pain Sales Share by Application (2023-2028)
    Table 42. Global Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Corticosteroid Injections for Joint Pain Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Corticosteroid Injections for Joint Pain Revenue Share by Application (2017-2022)
    Table 45. Global Corticosteroid Injections for Joint Pain Revenue Share by Application (2023-2028)
    Table 46. Corticosteroid Injections for Joint Pain Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Corticosteroid Injections for Joint Pain Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
    Table 49. North America Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
    Table 50. North America Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Corticosteroid Injections for Joint Pain Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
    Table 53. North America Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
    Table 54. North America Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Corticosteroid Injections for Joint Pain Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 57. North America Corticosteroid Injections for Joint Pain Sales by Country (2023-2028) & (K Units)
    Table 58. North America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Corticosteroid Injections for Joint Pain Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Corticosteroid Injections for Joint Pain Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Corticosteroid Injections for Joint Pain Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Corticosteroid Injections for Joint Pain Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Corticosteroid Injections for Joint Pain Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Corticosteroid Injections for Joint Pain Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Allergan Corporation Information
    Table 109. Allergan Description and Major Businesses
    Table 110. Allergan Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Allergan Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Allergan Recent Developments
    Table 113. Pfizer Corporation Information
    Table 114. Pfizer Description and Major Businesses
    Table 115. Pfizer Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Pfizer Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Pfizer Recent Developments
    Table 118. Sanofi Corporation Information
    Table 119. Sanofi Description and Major Businesses
    Table 120. Sanofi Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Sanofi Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Sanofi Recent Developments
    Table 123. Anika Therapeutics Corporation Information
    Table 124. Anika Therapeutics Description and Major Businesses
    Table 125. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Anika Therapeutics Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Anika Therapeutics Recent Developments
    Table 128. Ferring Corporation Information
    Table 129. Ferring Description and Major Businesses
    Table 130. Ferring Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Ferring Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Ferring Recent Developments
    Table 133. Bioventus Corporation Information
    Table 134. Bioventus Description and Major Businesses
    Table 135. Bioventus Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Bioventus Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Bioventus Recent Developments
    Table 138. Flexion Therapeutics Corporation Information
    Table 139. Flexion Therapeutics Description and Major Businesses
    Table 140. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Flexion Therapeutics Recent Developments
    Table 143. Zimmer Biomet Corporation Information
    Table 144. Zimmer Biomet Description and Major Businesses
    Table 145. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Zimmer Biomet Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Zimmer Biomet Recent Developments
    Table 148. SEIKAGAKU Corporation Information
    Table 149. SEIKAGAKU Description and Major Businesses
    Table 150. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. SEIKAGAKU Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. SEIKAGAKU Recent Developments
    Table 153. Chugai Pharma Corporation Information
    Table 154. Chugai Pharma Description and Major Businesses
    Table 155. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Chugai Pharma Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Chugai Pharma Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Corticosteroid Injections for Joint Pain Distributors List
    Table 161. Corticosteroid Injections for Joint Pain Customers List
    Table 162. Corticosteroid Injections for Joint Pain Market Trends
    Table 163. Corticosteroid Injections for Joint Pain Market Drivers
    Table 164. Corticosteroid Injections for Joint Pain Market Challenges
    Table 165. Corticosteroid Injections for Joint Pain Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Corticosteroid Injections for Joint Pain Product Picture
    Figure 3. Global Corticosteroid Injections for Joint Pain Market Share by Type in 2021 & 2028
    Figure 3. Knee & Ankle Product Picture
    Figure 4. Hip Joint Product Picture
    Figure 5. Shoulder & Elbow Product Picture
    Figure 6. Facet Joints of the Spine Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Corticosteroid Injections for Joint Pain Market Share by Application in 2021 & 2028
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. Online Pharmacies
    Figure 12. Corticosteroid Injections for Joint Pain Report Years Considered
    Figure 13. Global Corticosteroid Injections for Joint Pain Sales 2017-2028 (K Units)
    Figure 14. Global Corticosteroid Injections for Joint Pain Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Corticosteroid Injections for Joint Pain Revenue 2017-2028 (US$ Million)
    Figure 16. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2022)
    Figure 18. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2023-2028)
    Figure 19. North America Corticosteroid Injections for Joint Pain Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Corticosteroid Injections for Joint Pain Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Corticosteroid Injections for Joint Pain Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Corticosteroid Injections for Joint Pain Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Corticosteroid Injections for Joint Pain Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Corticosteroid Injections for Joint Pain Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Corticosteroid Injections for Joint Pain Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Corticosteroid Injections for Joint Pain Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Corticosteroid Injections for Joint Pain Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Corticosteroid Injections for Joint Pain Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Corticosteroid Injections for Joint Pain in the World: Market Share by Corticosteroid Injections for Joint Pain Revenue in 2021
    Figure 31. Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
    Figure 33. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
    Figure 34. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
    Figure 35. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
    Figure 36. North America Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
    Figure 37. North America Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
    Figure 38. North America Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
    Figure 39. North America Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
    Figure 40. North America Corticosteroid Injections for Joint Pain Sales Share by Country (2017-2028)
    Figure 41. North America Corticosteroid Injections for Joint Pain Revenue Share by Country (2017-2028)
    Figure 42. U.S. Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
    Figure 45. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
    Figure 47. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Corticosteroid Injections for Joint Pain Sales Share by Country (2017-2028)
    Figure 49. Europe Corticosteroid Injections for Joint Pain Revenue Share by Country (2017-2028)
    Figure 50. Germany Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 51. France Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Corticosteroid Injections for Joint Pain Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Corticosteroid Injections for Joint Pain Revenue Share by Region (2017-2028)
    Figure 61. China Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 64. India Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Corticosteroid Injections for Joint Pain Sales Share by Country (2017-2028)
    Figure 76. Latin America Corticosteroid Injections for Joint Pain Revenue Share by Country (2017-2028)
    Figure 77. Mexico Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Corticosteroid Injections for Joint Pain Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue Share by Country (2017-2028)
    Figure 86. Turkey Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (US$ Million)
    Figure 89. Corticosteroid Injections for Joint Pain Value Chain
    Figure 90. Corticosteroid Injections for Joint Pain Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Nebivolol Hydrochloride Market Insights Forecast to 2028
Global Nebivolol Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-12T7632
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nefopam Hydrochloride Market Insights Forecast to 2028
Global Nefopam Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-36U7490
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Naratriptan Hydrochloride Market Insights Forecast to 2028
Global Naratriptan Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-14C7602
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart